APA (7th ed.) Citation

TE, W., SM, G., PJ, K., JP, C., DJ, I., IN, M., . . . CB, R. (2008). Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group. Leukemia & lymphoma, 49(6), 1074. https://doi.org/10.1080/10428190801993470

Chicago Style (17th ed.) Citation

TE, Witzig, et al. "Salvage Chemotherapy with Rituximab DHAP for Relapsed Non-Hodgkin Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group." Leukemia & Lymphoma 49, no. 6 (2008): 1074. https://doi.org/10.1080/10428190801993470.

MLA (9th ed.) Citation

TE, Witzig, et al. "Salvage Chemotherapy with Rituximab DHAP for Relapsed Non-Hodgkin Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group." Leukemia & Lymphoma, vol. 49, no. 6, 2008, p. 1074, https://doi.org/10.1080/10428190801993470.